
    
      -  A Bayesian approach is considered for the analysis of this trial. The aim is to provide
           a stopping rule for inefficacy of the new dose.

        -  Two aspects are important to elucidate the mechanism of this treatment: dynamic
           investigations of perfusion and vasculature. Apart from participation to the dose
           reduction paragraphs of this study, patients will be also asked to undergo, at
           clinically relevant dose points, dynamic contrast enhanced (DEC) MRI scans and
           separately tumor biopsies.
    
  